SG3 Management, LLC - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 151 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.75 and the average weighting 0.3%.

Quarter-by-quarter ownership
SG3 Management, LLC ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$377,000
-66.0%
10,000
-84.7%
0.01%
-57.1%
Q4 2020$1,110,000
+293.6%
65,200
+8.7%
0.02%
+110.0%
Q3 2020$282,00060,0000.01%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Eventide Asset Management 601,000$24,587,0001.39%
HealthCor Management, L.P. 1,010,930$41,357,0001.39%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 86,500$3,535,0001.38%
PURA VIDA INVESTMENTS, LLC 75,000$3,068,0000.90%
BB BIOTECH AG 777,500$31,808,0000.88%
AWM Investment Company, Inc. 100,000$4,091,0000.71%
Granite Point Capital Management, L.P. 50,000$2,046,0000.43%
Rock Springs Capital Management LP 217,700$8,906,0000.41%
Crestline Management, LP 50,919$2,083,0000.29%
ADAGE CAPITAL PARTNERS GP, L.L.C. 2,432,700$99,522,0000.24%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders